A quick-growing malignant, trophoblastic, aggressive cancer that occurs in a woman’s uterus (womb).
Highly malignant neoplasm of the uterus or fallopian tube.
A rare type of cancer found in the uterus.
Rare and highly malignant tumor, usually of the uterus but may also develop at the site of an ectopic pregnancy. May occur during normal pregnancy or as a complication of hydatid mole. Some cases of long-term survival have been reported using the chemotherapeutic agent methotrexate.
A highly malignant tumor that invades the walls of the uterus. Choriocarcinoma usually appears months after a molar pregnancy, an ectopic pregnancy, or a miscarriage, although in about 15 percent of cases, it accompanies or follows normal pregnancies. Some choriocarcinomas develop from placental cells left behind after an abortion or pregnancy. Symptoms include vaginal bleeding and excessive nausea. Pelvic examination may show that the uterus is larger than expected. Urine and blood tests will show higher than normal levels of the hormone human chorionic gonadotropin (HCG).
A form of cancer affecting the chorion, in the treatment of which particularly impressive results are being obtained from the use of methotrexate.
An extremely rare, very malignant neoplasm, usually of the uterus but sometimes at the site of an ectopic pregnancy. Although the actual cause is unknown, it may occur following a hydatid mole, a normal pregnancy, or an abortion. This cancer may respond dramatically to combined modality therapy using surgery and chemotherapy.
Choriocarcinoma is an uncommon malignant tumor that originates from placental tissue within the uterus. Typically, it emerges as a complication of a hydatidiform mole, a benign tumor in placental tissue. However, it can also develop following a normal pregnancy, a miscarriage, or an abortion. In some cases, the tumor may not manifest until several months or even years after the pregnancy that triggered its formation.
Early symptoms of this condition may not be present. However, the presence of a choriocarcinoma can become evident through persistent vaginal bleeding following a miscarriage, abortion, or more than eight weeks after childbirth. If left untreated, the tumor can cause damage to the uterine walls, and the cancer cells may potentially spread through the bloodstream to the vagina, vulva, liver, lungs, brain, and bones.
Women who have undergone treatment for a hydatidiform mole receive regular screening through ultrasound scanning. Additionally, the levels of human chorionic gonadotropin (HCG), a hormone typically produced by the placenta, are measured in both blood and urine. Elevated levels of this hormone in the body are indicative of a potential association with choriocarcinoma.
The administration of anticancer medications is typically highly effective in treating choriocarcinoma. In some cases, a hysterectomy, which involves the surgical removal of the uterus, may also be deemed necessary as part of the treatment approach.